SCHEMBL20427017

SCHEMBL20427017

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-n4ccc5ccc6c(c54)-c4ccccc4C6(c4ccccc4)c4ccccc4)cc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.36
▸ MAPT P10636 7/20 0.36
▸ MEN1 O00255 6/20 0.36
▸ HPGD P15428 5/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ TDP1 Q9NUW8 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ NPSR1 Q6W5P4 3/20 0.31
▸ CYP2C19 P33261 3/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ CYP2C9 P11712 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20427015 0.94 KDM4E (0.32) KMT2AMAPTMEN1KDM4ELMNA
SCHEMBL20427033 0.89 CYP1A2 (0.31) KMT2AMAPTMEN1LMNATDP1
SCHEMBL20427006 0.89 PDE6D (0.33) KMT2AMAPTMEN1KDM4ELMNA
SCHEMBL20427003 0.87 MAPT (0.33) KMT2AMAPTMEN1HPGDALDH1A1
SCHEMBL20427004 0.85 MAPT (0.35) KMT2AMAPTNPSR1CYP2C19CYP1A2
SCHEMBL20427016 0.85 MEN1 (0.33) KMT2AMAPTMEN1KDM4ELMNA
SCHEMBL20426974 0.84 KMT2A (0.35) KMT2AMAPTMEN1HPGDALDH1A1
SCHEMBL20427023 0.84 CHRNB2 (0.33) —
SCHEMBL20426988 0.84 KDM4E (0.35) KMT2AMAPTMEN1KDM4ELMNA
SCHEMBL20427008 0.84 NPC1 (0.31) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU KMT2A 2669/4885MAPT 459/4885MEN1 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback